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Compostos orgânicos de estanho, TBT, aorta de rato, A7r5, patch clamp, 
banho de órgãos  
Resumo  
 
 
Os compostos orgânicos de estanho são uma importante classe de compostos 
organometálicos produzidos pelo homem, e o tributilestanho (TBT) é um dos 
químicos mais estudados dentro desta classe. O TBT atua como um potente 
disruptor endócrino, sendo também considerado como um composto 
obesogénico, imunotóxico e neurotóxico. A exposição humana a este e outros 
compostos orgânicos de estanho deve-se à sua vasta utilização em aplicações 
comerciais como estabilizadores de plásticos, agentes catalíticos e biocidas 
industriais. A sua utilização como agentes catalíticos na produção de silicones 
faz com que estes compostos estejam presentes em vários produtos à base de 
silicone, incluindo os usados em aplicações biomédicas como implantes 
mamários e válvulas cardíacas, o que pode constituir uma fonte potencial de 
exposição para os humanos. De acordo com a Organização Mundial de 
Saúde, as doenças cardiovasculares estão a aumentar e são consideradas 
como a principal causa de morte a nível mundial. Tendo isto em conta, as 
agências reguladoras recomendam o estudo da toxicidade dos compostos 
orgânicos de estanho. Considerando o número limitado de estudos sobre os 
efeitos cardiovasculares dos compostos orgânicos de estanho, o presente 
trabalho pretende elucidar os efeitos do TBT ao nível vascular.  
Os efeitos do TBT na contractilidade de artérias de rato (aorta) foram 
estudados pela técnica do banho de órgãos e a medição dos canais de cálcio 
tipo L foi realizada em A7r5 (linha celular de músculo liso vascular derivada de 
aorta embrionária de rato) através da técnica do patch clamp na configuração 
whole cell. Os resultados obtidos demonstram que o TBT parece induzir 
relaxamento nas artérias sem endotélio contraídas previamente com 
noradrenalina e com cloreto de potássio, mas esse efeito não é 
significativamente diferente do controlo de solvente usado. Nas experiências 
de eletrofisiologia a inibição das correntes de cálcio através dos canais de 
cálcio tipo L nas células A7r5 também não mostrou ser significativamente 
diferente do controlo, o que parece demonstrar que o modo de ação pelo qual 
o TBT induz efeito nas células vasculares é mais complexo e envolve outras 
vias. 
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Abstract  
 
Organotins are an important class man made organometallic compounds and 
tributyltin (TBT) is one of the most studied chemicals within this class. TBT is a 
potent endocrine disruptor being also considered as an obesogenic, 
immunotoxic and neurotoxic compound. Humans were exposed to this and 
other organotin compounds as a consequence of their widespread commercial 
applications including plastic stabilizers, catalytic agents and industrial 
biocides. Their utilization as catalytic agents in the production of silicones leads 
to the presence of these chemicals in silicone based products including those 
used in biomedical applications such as breast implants and cardiac valves 
which may constitute a potential source of exposure. According to the World 
Health Organization cardiovascular diseases are sharply increasing and 
constitute the prime cause of death globally. Taking this into account, 
regulatory agencies, recommend the study of organotin compounds toxicity. 
Considering the limited number of studies on the cardiovascular effects of 
organotins, the present thesis aims to elucidate the effects of TBT at the 
vascular level.  
The study of TBT effect on the contractility of rat artery (aorta) was performed 
by the organ bath technique and the L-type calcium channels in A7r5 (cell line 
derived from the smooth muscle of embryonic rat aorta) was measured by 
whole-cell configuration of the patch clamp technique.  
The obtained results demonstrated that TBT seems to relax the rat aorta 
without endothelium contracted by noradrenaline and potassium chloride but 
this effect is not significantly different from the respectively ethanol control. The  
electrophysiological experiments demonstrated that the inhibition of the calcium 
current by the L-type calcium channels in the A7r5 vascular smooth muscle 
cells was also not significantly different, which suggests that probably the mode 
of action of TBT is more complex and involves other pathways.  
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1.1 Organotin compounds (OTs) and tributyltin (TBT)  
1.1.1 Chemical and physical properties of OTs 
 
Organotin compounds (OTs) are characterized by a tin (Sn) atom covalently bound to one 
or more organic substituents (Hoch, 2001). The general formula of organotins is RSnX in which R is 
an organic group (such as alkyl groups like methyl, ethyl, propyl, butyl, or aryl groups like phenyl) 
and X is an anionic group (such as chloride, fluoride, oxide, hydroxyl, carboxylate and thiolate) 
(Hoch, 2001). OTs are organometals essentially produced by humans except methyltins, which can 
also be produced naturally by bacteria through biomethylation (Guard et al., 1981). OTs are 
grouped into mono-, di-, tri-, and tetrasubstituted compounds according to the number of organic 
groups (Hoch, 2001). The physical and chemical properties of these compounds vary considerably 
with the number and nature of the R groups and type of ligand. Their toxicity is also strongly 
influenced by these factors. Basically inorganic tin is non-toxic and trisubstituted compounds are 
the most toxic (Fent, 2006; Hoch, 2001). The solubility of organotins in water is very low and 
depends on the temperature, salinity, pH and concentration of suspended particles. These 
compounds have a high affinity for organic solvents and lipids showing a high octanol/water 
partition coefficient1 Kow (WHO, 1990). 
 
Table 1. Examples of selected organotin compounds with their respective formula.  Adapted from Sousa 
ACA et al. (2013). 
Class Compound Abbreviation Formula 
 Monobutyltin  MBT C4H9Sn 
Butyltins (BTs) Dibutyltin DBT C8H18Sn 
 Tributyltin TBT C12H27Sn 
 Monophenyltin  MPT C6H7Sn 
Phenyltins (PTs) Diphenyltin  DPT C12H10Sn 
 Triphenyltin TPT C18H15Sn 
                                                          
1
 The octanol/water partition coefficient (Kow) describes the partitioning of an organic chemical between octanol and 
water. Octanol is believed to best imitate the fatty structures in plant and animal tissues (Kenaga and Goring, 1980). 
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 Monooctyltin MOT C8H20Sn 
Octyltins (OcTs) Dioctyltin  DOT C16H34Sn 
 Trioctyltin   TOT C24H51Sn 
 
1.1.2 Production and applications 
 
The industrial manufacture of organotins started during the 1940’s when the plastic 
industry began to expand, in particular the one responsible for the polyvinyl chloride (PVC) 
production (Sousa ACA et al., 2013). In fact, PVC industry produces about 76% of the total annual 
organotin manufacture, mainly dibutyltins, dioctyltins and mono substituted compounds (Sousa 
ACA et al., 2013). Organotin compounds are used as additives for thermal and light stabilization in 
PVC production to prevent its discoloration and embrittlement under the influence of light and 
heat, because polyvinyl chloride has the tendency to decompose upon heating (180-200ºC) or loss 
the HCl from the polymer with a prolonged exposure to light (Hoch, 2001). Organotin-stabilized 
PVC has several applications as packaging materials (e.g. food-contact plastics, packs for medical 
applications, packs for cosmetics, housewares and bottles); piping of potable water, wastewater 
and drainage water; window frames and coating materials (RPA, 2005). Another important 
application of organotins is their use as catalysts in the production of silicones. The most used OTs 
in the silicone manufacture are dibutyltins and dioctyltins. There are several products containing 
silicones catalysed by organotins,  such as healthcare devices (e.g. breast implants, valves, tubes 
and bags), personal care items, textiles, construction materials, automotive and sports items 
(RPA, 2005; SCHER, 2006). Organotin catalysts are also used to produce  a wide variety of 
polyurethane applications for adhesives/sealants, for the automotive industry, for the 
construction industry and for several appliances, binders, coatings, elastomers, footwear and 
furniture (RPA, 2005). According to Hoch (2001), OTs belongs to the most wide organometallic 
compounds group with more than 800 different organotins known and as of 2008 with an 
estimated annual production of about 60,000 tons (Nath, 2008).  
Organotin compounds have excellent biocidal properties in particular tri-substituted 
organotins. In the late of 1950’s, tributyltin (TBT) and triphenyltin (TPT) were used as actives 
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biocides in antifouling paints formulations to prevent the biofouling2 (Sousa ACA et al., 2013). In 
agriculture, tri-substituted organotins were also used as pesticides, fungicides and as wood 
preservers (Hoch, 2001). Besides all of these applications, organotins could also be found in 
surface disinfectants (including the ones used in health care facilities), laundry sanitizers, rodent-
repellents, scintillation detectors for ɤ- and X-rays, ballistic additives, ionophores in liquid 
membrane ion-selective electrodes and pharmaceuticals (e.g. anti-inflammatory and cancer 
treatments drugs) (see Sousa ACA et al. (2013)).  
In general, mono and di-substitued organotins are used as PVC stabilizers, as catalysts in 
the production of polyurethane foams and in glass coating; tri-substitued organotins are used as 
biocides, pesticides and as intermediates in the production of other chemicals, and tetra-
substitued compounds are used as intermediates in synthesis of other organic chemicals and in oil 
stabilizers (de Carvalho Oliveira and Santelli, 2010; RPA, 2005; Sousa et al., 2014a). 
 
1.1.3 Regulation on organotin compounds 
1.1.3.1 European legislation on organotins  
 
A compilation on the regulations regarding organotin compounds in Europe is provided by 
Sousa ACA et al. (2013). The first regulation on the use of organotins was adopted as a 
consequence of adverse effects of tributyltin pollution. Tributyltin, and also triphenyltin, were 
used as active biocides in antifouling paints formulations. In 1989, the European Union (EU) 
introduced the Directive 89/677/EEC, banning the use of TBT and TPT on small boats (<25m). This 
partial ban was however not effective on reducing the levels of TBT in the environment (Sousa et 
al., 2013). In 2001, the International Maritime Organization (IMO) decided to ban TBT on a global 
scale through the International Convention on Control of Harmful Antifouling Systems on Ships 
(AFS Convention). This global ban entered into force in 2008. Nevertheless, in 2003, the European 
Union anticipated this global ban through the Directive 2002/62/EC and Regulation 782/2003 and 
therefore, in the EU the use of organotin compounds in antifouling paints was completely banned 
since 2003 (Sousa ACA et al., 2013).   
Organotin compounds are also regulated in the European Union by the EC Regulation 
1907/2006 on the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) 
                                                          
2
 Biofouling can be defined as the settlement and growth of a variety of aquatic organisms on structures immersed in 
seawater, such as ships’ hulls, sonar equipment, seawater cooling pipes and navigation buoys (Omae, 2003).  
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and their use is included in Annex XVII of the regulation that restricts the manufacture, placing on 
the market and use of certain dangerous substances, preparations and articles.  According to the 
REACH directive, organotins: 
1) “Shall not be placed on the market, or used, as substances or in mixtures where the 
substance or mixture is acting as biocide in free association paint. 
2) Shall not be placed on the market, or used, as substances or in mixtures where the 
substance or mixture acts as biocide to prevent the fouling by micro-organisms, plants or 
animals of: 
a)  All craft irrespective of their length intended for the use in marine, coastal, estuarine 
and inland waterways and lakes; 
b)  Cages, floats, nets and any other appliances or equipment used for fish or shellfish 
farming; 
c)  Any totally or partly submerged appliance or equipment. 
3) Shall not be placed on the market, or used, as substance or in mixture where the 
substance or mixture is intended for use in the treatment of industrial waters“ (cited from 
Annex XVII). 
 
Due the wide commercial applications as plastic stabilizers, catalytic agents, industrial 
biocides, pesticides and glass coating, further restrictions on OTs usage were further adopted by 
the European Commission. Hence, in 2009, EC Decision 2009/425/EC restricted the use of 
dibutyltin, dioctyltin and tri-substituted OTs. In 2010 this decision was incorporated into Annex 
XVII of REACH via regulation (EU) 276/2010. 
 
Table 2. Summary of organotin compounds requirements under European Regulations (EU) 276/2010 
amending Annex XVII of REACH. The concentration in the mixture or the article, or part thereof, is greater 
than the equivalent of 0.1% by weight of tin. TBT: tributyltin, TPT: triphenyltin; DBT: dibutyltin, DOT: 
dioctyltin, PVC: polyvinyl chloride. Adapted from Sousa et al. (2013). 
 
Substance Products Effective form 
TBT and TPT  Articles or part of articles 1 July 2010 
 Mixtures 
 Articles of parte of articles (except food 
contact materials) 
1 January 2012 
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DBT  One-component and two-component room 
temperature vulcanization sealants and 
adhesives 
 Paints and coatings containing DBT 
compounds as catalysts when applied on 
articles 
 Soft polyvinyl chloride (PVC) profiles 
whether by themselves or coextruded with 
hard PVC 
 Fabrics coated with PVC containing DBT 
compounds as stabilizers when intended for 
outdoor applications 
 Outdoor rainwater pipes, gutters and 
fittings, as well as covering material for 
roofing and facades 
1 January 2015 
DOT  Textile articles intended to come into 
contact with the skin 
 Gloves 
 Footwear or part of footwear intended to 
come into contact with the skin 
 Wall and floor coverings 
 Childcare articles 
 Female hygiene products 
 Nappies 
 Two-component room temperature 
vulcanization moulding kits 
1 January 2012 
 
1.1.4 Tributyltin as a case study 
1.1.4.1 TBT chemical characterization 
 
TBT (Figure 1) is characterized by the presence of covalent bonds between a tin atom and 
three carbon atoms. The solubility in water is low varying according to the pH, temperature, and 
anions present in the water. TBT is soluble in lipids and very soluble in organic solvents (e.g. 
ethanol) (IPCS, 1990). The lipoaffinity of TBT is well demonstrated by its octanol-water partition 
constant (Kow) with values between 3.49 and 5.07 depending on the TBT chemical speciation 
(Arnold et al., 1997). 
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Figure 1. Chemical structure of TBT. Adapted from PubChem (www.pubchem.ncbi.nlm.nih.gov).   
 
1.1.4.2 Bioaccumulation 
 
Several studies have reported high concentrations of TBT in some fishes and aquatic 
invertebrates, such as gastropods and filter-feeding organisms (Guérin et al., 2007; Okoro et al., 
2011; Santos et al., 2009). Such high concentrations were related with the massive utilization of 
tributyltin as biocide in antifouling paints to prevent biofouling in the hulls of ships. As a 
consequence of its widespread use, the inputs of TBT into the aquatic environment were huge 
(Sousa ACA et al., 2013). Once in the marine environment, TBT adsorves to organic matter and 
settles down in sediments where it can remain for decades (Fent, 2006). Several organisms at the 
base of the food chain have the capacity to accumulate TBT from the water and this compound is 
transferred to consumers and top predators, especially mammals and seabirds (Iwata et al., 1995; 
Takahashi et al., 1999; Tanabe et al., 1998) which lead to an increased accumulation in the food 
chain (Mamelona and Pelletier, 2003). In Portugal, the levels of organotins in seafood were 
measured during 2002 and 2003 and butyltins were detected in all the analysed groups (fish, 
crustaceans, bivalves and cephalopods).   In bivalves, for example, TBT was detected with values 
up to 275 ng TBT g-1 wet weight (Santos et al., 2009). However, recently, the TBT levels in seafood 
have decreased as a consequence of the TBT global ban (Sousa ACA et al., 2013).  
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1.1.4.3 Absorption and distribution 
 
The toxic effects of organotins are mediated by the tissues that serve as interface 
between the environment and the organism (Pagliarani et al., 2013). In vertebrates, for example,  
the digestive system is the primary absorption site and the liver is the main detoxification site 
(Pagliarani et al., 2013). In mammals, the absorption of TBT occurs in the intestinal epithelium 
that is the main barrier before reaching the bloodstream (Azenha et al., 2004) however the 
absorption through the skin in mammals also occurs (IPCS, 1990). Several studies described the 
absorption of TBT and other organotins in vitro using cell lines and in vivo with rats and/or mice. 
Evans et al. (1979) and Iwai et al. (1982) described that following TBT oral administration in rats 
and mice, this compound was absorbed from the duodenum, jejunum and ileum. TBT effects on 
the gastrointestinal tract include an increase of intestinal heme oxygenase and a  reduction of 
intestinal P450, which suggests that  TBT may affect the ability of the gastrointestinal tract to 
metabolize drugs or other xenobiotics (Rosenberg and Kappas, 1989).   
Azenha et al. (2004) performed a series of in vitro studies using an intestinal cell line 
model to access the intestinal permeation of organotins. Their results demonstrated that butyltins 
including TBT have low permeability but the absorption is greatly assisted by proteins in the 
circulation.  A study performed by Evans et al. (1979) demonstrated that when adult female mice 
ingests labelled 14C-TBT trough  drinking water, the highest quantity of the labelled compound is 
found in kidney followed by fat, liver, spleen, lung, brain, muscle and blood. Fifteen days after the 
end of the treatment, most of the tissues had lost most of the labelled TBT but the fat, lung and 
kidney still showed detectable levels suggestion that it is retained in this tissues/organs. In a 
multigenerational study with rats it was found that TBT speciation in the liver reflected the TBT 
degradation metabolism with  [MBT] > [DBT] > [TBT], on the other hand, in the brain and fat, the 
quantities were reversed with [TBT] > [DBT] > [MBT]  (Omura et al., 2003) which provides further 
evidences that the TBT detoxification occurs mainly in the liver.  More recently,  Cooke et al. 
(2008) studied the distribution and speciation of organotins in tissues of rat dams, fetuses and 
neonates and detected the presence of TBT in liver, brain and placenta. It was found that TBT 
crossed the placenta and accumulated in the fetal tissues, but the transfer of TBT to neonatal 
pups would be low as the levels of TBT in dams’ milk were almost undetectable (Cooke et al., 
2008).  
Besides the in vitro and in vivo studies on absorption and distribution of organotins in 
rodent models, levels of these compounds were already detected in human biological tissues and 
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fluids. Figure 2 provides a summary of the maximum organotin levels detected in humans (for a 
complete list of references see: Sousa ACA et al. (2013)).  
 
 
 
Figure 2. Summary of the highest organotin values detected in human tissues and fluids. MBT: 
Monobutyltin, DBT: Dibutyltin, TBT: Tributyltin, MPT: Monophenyltin, DPT: Diphenyltin, TPT: Triphenyltin, 
MOT: Monooctyltin, DOT: Dioctyltin, MMT: Monomethyltin, DMT: Dimethyltin, TMT: Trimethyltin. Adapted 
from Sousa ACA et al., (2013). 
 
1.2 Human exposure to OTs 
1.2.1 Pathways of exposure 
 
Organotins can be found almost everywhere due its widespread use and therefore humans 
might be exposed to these compounds through several routes (Sousa ACA et al., 2013). Diet was 
traditionally considered an important source of OTs towards humans, particularly seafood rich 
diets where the TBT levels tend to be higher due to the global marine contamination by TBT 
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(Sousa ACA et al., 2013). However recent reports disclose that OTs levels in diet samples are 
sharply decreasing and therefore diet is no longer the major source of OTs (Sousa et al., 2014b). 
Several consumer products might still contain organotin compounds (see section 1.3.1.) such 
products include for example: pyjamas, cloths, shoes, non-allergic pillows, wallpaper, curtains, 
carpets  and furniture (Sousa ACA et al., 2013). Beside these consumer products, silicone items 
may also contain OTs since they are used as catalysts during the production process. This fact is 
particularly important if we consider human exposure in a clinical  context since healthcare 
devices such as breast implants and cardiac valves are made of silicone (SCHER, 2006). Drinking 
water transported by PVC pipes can also be considered as a way of exposure to these chemicals 
once organotins are used as additives for thermal and light stabilizers in PVC plastics. It was 
demonstrated that OTs can leach into the water flowing through PVC pipes (Adams et al., 2011; 
Forsyth and Jay, 1997; Sousa ACA et al., 2013). Another important source of organotins to 
consider is indoor dust.  Organotins may leach from several appliances and consumer products 
with OTs in their composition and will end up in dust. As  people spend most of their times in 
indoor environments the presence of organotins in the house dust contributes to human 
exposure (Fromme et al., 2005; Kannan et al., 2010; Santillo et al., 2001; Santillo et al., 2003; 
Sousa et al., 2014a). 
 
1.3 Adverse OTs effects – in vitro and in vivo evidences 
 
 
Organotins and TBT in particular have several adverse effects towards a wide range of 
organisms including bacteria and reaching mammals (see Sousa ACA et al., 2013). The first 
documented example of TBT deleterious effects occurred in marine organisms and it was also in 
marine organisms that a sexual disorder classified as imposex (superimposition of male characters 
into female gastropods) was described (Smith, 1971). This phenomenon soon became known as 
the best example of endocrine disruption in wildlife and from here the interest to study 
organotins toxicity, especially TBT increased. TBT is considered as a potent endocrine disruptor3, 
with immunotoxic potential and recently it was also classified as an obesogenic compound. A brief 
overview of TBT and organotin compounds toxicity towards vertebrates using both in vivo and in 
vitro models is provided in the next section.    
                                                          
3
 According to the Endocrine Society an endocrine disruptor is an exogenous chemical, or mixture of chemicals, that 
interferes with any aspect of hormone action  (Zoeller et al., 2012).  
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1.3.1 Obesogenecity 
 
Obesogenic compounds are defined as chemicals that can have an influence on obesity 
development by inappropriately altering lipid homeostasis to promote adipogenesis and lipid 
accumulation (Grün and Blumberg, 2006, 2007, 2009). The Obesogen Hypothesis proposes that 
exposure to environmental chemicals during critical stages of development such as an early-life or 
long-term (chronic) exposures might have an influence on the promotion of metabolic diseases 
such as obesity and obesity-related disorders (Grün, 2014; Grün and Blumberg, 2009). 
Compounds with potent endocrine-disrupting properties are considered as obesogens and TBT is 
considered the model obesogen (Pereira-Fernandes et al., 2013). TBT is an obesogen because 
activates the peroxisome proliferator activated receptor gamma (PPARɤ) that is a nuclear 
receptor with a crucial role on the homeostatic control over energy, lipid and glucose metabolism 
(Grün and Blumberg, 2007). The molecular mechanism of adipocyte differentiation evolves the 
PPARɤ that forms heterodimers with retinoid X receptor (RXR) that  regulates the expression of 
target genes at transcriptional level (Tontonoz and Spiegelman, 2008). Hence, PPARɤ and RXR 
heterodimer acts as a metabolic sensor that regulates adipocyte function, number and size (Grün 
and Blumberg, 2009). Various studies demonstrated that TBT induces adipogenesis in vitro and in 
vivo by activating PPARɤ and RXR and predisposing multipotent mesenchymal stem cells (MSCs) 
to differentiate into adipocytes (Grün et al., 2006; Kirchner et al., 2010). In vitro studies using 3T3-
L1 preadipocyte cell line model, human and mouse MSCs demonstrated that TBT exposure 
induced their differentiation into mature adipocytes (Carfi et al., 2008; Grün and Blumberg, 2006; 
Kirchner et al., 2010). In vivo studies showed an increase of adipose mass in different vertebrate 
model organisms including  frogs and mice (Grün et al., 2006). Moreover, the obesogenic 
capacities of TBT have been described in salmonids, snails and crustaceans (Janer et al., 2007; 
Jordão et al., 2015; Meador et al., 2011). In utero studies with mice further demonstrated that 
TBT increases adiposity of mice later in life (Grün and Blumberg, 2006). More recently, a cohort 
study demonstrated that placental TBT concentrations are associated with increased weight gain 
in human male infants at 3 months of age (Rantakokko et al., 2014).  
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1.3.2 Immunotoxicity  
 
It is well known that immune system can be target of several compounds with the capacity to 
modify one or more immune functions resulting in adverse effects to the host’s health (Corsini et 
al., 2013). Several studies have addressed the immunotoxic potential of organotins, and a 
thorough  review of those studies is provided by Hendriksen et al. (2014). In this section only a 
brief overview of those effects is provided.  
The first study that demonstrated the immunotoxic properties of organotins was conducted 
by Snoeij et al. (1985). In this study, rats were exposed for 2 weeks to several organotins including 
TBT and TPT at two different concentrations (15 and 150 ppm), and the obtained results 
demonstrated that both TBT and TPT reduced thymus weight in a dose-related manner while liver 
weights increased. These authors latter found out that red blood cells were the most resistant to 
OTs, and that bone marrow cells were less sensitive than thymocytes (Snoeij et al., 1986).   
Further evidences on the impact of OTs in thymocites continued to emerge. Raffray and Cohen 
(1991) for example, exposed  immature rat thymocytes to TBT and they observed that low TBT 
concentrations (0.1 and 1 µM) induce programmed cell death (apoptosis) while higher 
concentrations (5 µM) leads to a cell death with necrosis characteristics.  
Other in vitro studies using natural killer cells isolated from peripheral blood of healthy adults 
showed that when these cells are exposed to TBT their ability to destroy targets such as tumor 
cells decreases (Whalen et al., 1999). Additional studies demonstrated that TBT induces apoptosis 
in several target cells such as monocytes (Ghibelli et al., 1995) and lympochytes (Stridh et al., 
2001; Stridh et al., 1999).  
As described earlier TBT interacts with nuclear receptors PPARɤ and RXR leading to adipocyte 
differentiation in 3T3-L1 preadipocyte cell line model, human and mouse MSCs (Grün and 
Blumberg, 2006; Carfi et al., 2008; Kirchner et al., 2010). Since adipocytes influence 
haematopoiesis (development of different blood cells) through the expression of cytokines and 
adhesion molecules the role of adipocyte-stimulating effect of TBT in human bone marrow 
cultures has also been explored. Carfi and co-workers demonstrated that TBT also induces 
adipocyte differentiation in human bone marrow cultures and that it induces a reduction in the 
number of chemokines, interleukins and growth factors which suggests that TBT induces 
adipocyte differentiation whilst reducing  haematopoietic factors (Carfi et al., 2008). All these 
evidences suggests that TBT immunotoxicity may result from interference with more than one 
process and cell types (Carfi et al., 2010).  
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In humans, exposure to TBT has also been associated with induction or exacerbation of 
allergic diseases such as allergic airway inflammation (Kato et al., 2004).  
The TBT mode of action is still under debate but the available studies suggest that calcium is 
involved in TBT toxicity. It has been demonstrated in several in vitro studies that TBT releases 
calcium from an intracellular source and induces calcium influx from outside the cells (See 
Hendriksen et al., 2014 for a complete description of those studies).  This theory was further 
supported by in vitro studies using calcium chelators that decreased the toxicity of TBT. Figure 3 
depicts the proposed mode of action of TBT. TBT also affect voltage-gated K+ current in human 
peripherical lymphocytes (Oortgiesen et al., 1996), however as stated by Hendriksen et al. 2014, 
“it remains to be assessed whether the effects of TBT on the voltage-gated K+ current are direct 
effects on the channels or secondary effects, for example, caused by increased intracellular 
calcium levels”.  
Figure 3. Illustration of the mode of action of TBTO in Jurkat T cells. TBTO initially acts on the ER and exerts 
ER stress inducing Ca
2+
 release from the ER lumen into the cytoplasm through the calcium channel IP3 
receptor (IP3R). In addition, TBTO might inhibit SERCA and therewith blocks Ca
2+
 influx from cytoplasm to 
the ER which also contributes to an increased calcium level in the cytoplasm. This small cytoplasmic Ca
2+
 
peak triggers a more pronounced Ca
2+
 influx into the cell through CRAC channels within the plasma 
membrane. The increased cytoplasmic Ca
2+
 level activates the calcium binding proteins calcineurin and M-
calpain. Activated calcineurin dephosphorylates NFAT leading to its translocation to the nucleus and 
induction of expression of NFAT target genes (FASL, NUR77 and cytokines) resulting in T cell activation. 
Activation of M-calpain cleaves ER resident caspase-4. Furthermore, oxidative stress is induced by reactive 
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oxygen species that are produced in the ER due to ER stress and in the mitochondria due to the elevated 
cytoplasmic Ca
2+
 levels. Both, ER stress and increased Ca
2+
 levels activate NF-kB pathway. ER stress also 
induces activation of apoptosis-promoting proteins including DDIT3 and ATF3. Finally, the activated 
caspases induce apoptosis.  Figure  from Katika et al. (2012). 
 
Overall, these changes in intracellular calcium levels may affect all cell types, since ER stress is 
common in all cells.  However, immune cells are more sensitive to ER probably as a consequence 
of T-cell activation in response to Ca2+ released from the ER (Hendriksen et al., 2014; Kovalovsky 
et al., 2010). Despite these evidences supporting the Ca+2 dependent pathway, there are studies 
suggesting that the mechanism of OTs toxicity may be Ca+2 independent (Cima and Ballarin, 2012). 
Such Ca+2 independent mode of action include for example  inhibition of oxidative 
phosphorylation and ATP synthase and irreversible interactions with the thiol groups of many 
proteins and peptides (Cima and Ballarin, 2012). Figure 4 depicts the summary of pathways 
involved in immunotoxic mechanisms of action of OTs (Ca+2 dependent and independent) 
according to Cima and Ballarin (2012). Divided in Ca2+-dependent (red arrows) and Ca2+-
independent (blue arrows).  
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Summary of pathways involved in immunotoxic mechanisms of action of OTs, conventionally 
divided in Ca
2+
-dependent (red arrows) and Ca
2+
-independent (blue arrows). In Ca
2+
-dependent 
mechanisms, OTs directly interact with calcium-activated calmodulin causing a complex formation 
preventing the regulative activity of calmodulin on the calmodulin-dependent Ca
2+
-ATPase that leads to 
sustained increase of cytosolic calcium ion concentration. This takes part in a multifactorial apoptotic 
process, involving endonuclease activation. In Ca
2+
-independent mechanisms, OTs impair mitochondrial 
oxidative phosphorylation, oxidise glutathione and inhibit several thiol-containing and GSH-dependent 
enzymes like glutathione S-transferase (GST) and glutathione peroxidise (GPX), making exposed organisms 
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more vulnerable to oxidative stress. These mechanisms are synergistic since increase in cytosolic calcium is 
provoked by the presence of high amount of cytosolic oxidises glutathione that causes stimulation of 
calcium-releasing property of IP3 receptor. Cytoskeletal protein depolymerisation is due to both cytosolic 
calcium increase and extensive oxidation of their thiol groups causing severe morphological change, 
chemotaxis failure and phagocytosis inhibition. Figure from Cima and Ballarin (2012). 
 
1.3.3 Cardiotoxicity 
 
Organotin compounds have been reported to interfere with the cardiovascular system in 
animal models (Nath, 2008). Most of the available studies investigated the effects of OTs in rats 
and mice, but some work dated back from 1975 also addressed the effects of OTs in rabbits, cats 
and dogs (see Nath, 2008 for details).   
Studies on tributyltin oxide pharmacokinetics in rats, rabbits and dogs showed that TBT 
causes a depression of the vascular smooth muscle and a fall in the blood pressure (Truhaut et al 
1976 in Nath, 2008). Rabbits when exposed to alkyltins, for example, exhibit vasodilatation 
(Stoner et al. 1995 in Nath, 2008). Cats when exposed to triphenyltin exhibit an increase in the 
blood pressure if exposed to a single dose (1mg/kg triphenyltin acetate) and arterial hypotension 
if the administration is repeated at 20-60 min intervals (Tauberger, 1963 in Nath, 2008).  
Several in vivo and in vitro studies suggest that organic derivatives of tin, including TBT 
compounds, inhibit the cardiac sarcoplasmic reticulum (SR) Ca+2 transport and affect the Na+-
pump activity among other possible effects (see Nath, 2008 for a complete description of the 
available studies and proposed mechanisms of action). 
Kodavanti et al. (1991) performed several of experiments to assess the effect of TBT, and 
other organotins (triethyltin and trimethyltin) on the rat cardiac SR Ca2+ pump as well as on SR 
proteins. They reported that all of the tested organotin compounds inhibited cardiac sarcoplasmic 
reticulum 45Ca uptake and Ca2+-ATPase in a concentration-dependent manner. These results 
suggest that these OTs may be affecting Ca2+ pumping mechanisms through the alteration of 
phosphorylation of specific proteins (such as phospholamban4) in rat cardiac sarcoplasmic 
reticulum (Kodavanti et al., 1991). These evidences are extremely important  because the 
sarcoplasmic reticulum calcium pump together with phosphorylation of specific proteins have an 
important role in myocardial contraction and relaxation and if any compound alters this 
mechanism it obviously affects the normal functioning of the heart (Nath, 2008).  
                                                          
4
 Phospholamban in an integral sarcoplasmic reticulum protein that is expressed predominantly in cardiac muscle and 
in small amounts in skeletal muscle, smooth muscles and endothelial cells (Koss and Kranias, 1996; Sutliff et al., 1999). 
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Further in vivo and in vitro studies, reviewed by Nath (2008)  also demonstrated that 
organotin complexes, particularly the ones derivatives of aminoacids, dipeptides, triglycine,  
thymidine and umbelliferrone may act as direct vasodilators on the smooth muscles on blood 
cells, exhibiting potent anti-hypertensive activity and therefore their use as hypertensive drugs in 
under appraisal (Nath, 2008). 
More recently, dos Santos et al. (2012) investigated the influence of TBT (100ng/kg) on the 
coronary function of female rats and demonstrated that this organotin impairs the vasodilation 
induced by 17β-estradiol in isolated rat hearts. 17β-estradiol is a sex hormone that is involved in 
the protection against cardiovascular diseases by reducing the coronary artery disease via 
coronary vasodilation (Dubey and Jackson, 2001). Dos Santos et al., (2012) study demonstrated 
that the group of rats treated with TBT had decreased 17β-estradiol serum levels that were 
accompanied by an increase in serum progesterone levels, but maintenance in testosterone 
levels. The rat’s heart of the TBT exposed group exhibited higher percentages of collagen in the 
myocardium, which according to the authors may impair cardiac function due to the presence of 
fibrosis. Furthermore, the TBT exposed group disclosed an arterial wall surrounded by 
inflammatory cells and an increase in mast cells5 accompanied by an endothelial denudation. 
Based on these results the authors, concluded that TBT exposure may be a potential risk factor for 
cardiovascular disorders in rats  (dos Santos et al., 2012). The same team continue to work on the 
vascular effects of TBT and studied the effect of TBT in vascular reactivity of isolated aortic rings 
of female rats (Rodrigues et al., 2014).  Female rats were treated daily by gavage for a period of 
15 days with TBT (100ng/kg). The obtained results disclosed once again a decrease in serum 17β-
estradiol levels and an increase in collagen, accompanied this time with reduced α1-smooth 
muscle actin. Overall, this study allowed the authors to conclude that TBT decreases the vascular 
reactivity of female rat aorta by a mechanism that involves an imbalance in the effects of some 
endothelial factors as nitric oxide, K+ channels and reactive oxygen species (ROS).      
 
 
 
 
 
                                                          
5
 Mast cells are involved in the first line defence against pathogens and represent important mediators in diseases. 
These cells are laden with granules containing a wide variety of vasoconstrictors (Bot et al., 2008). 
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1.4 Objectives, motivation and thesis layout  
 
 
The objective of the current work is to elucidate the vascular effects of TBT trough in vitro 
experiments. This rationale is based on the fact that TBT is a widespread environmental 
contaminant to which humans are presumably exposed and on the fact that the prevalence of 
cardiovascular diseases in human population in sharply increasing. Furthermore, regulatory 
agencies including the Scientific Committee on Health and Environmental Risks (SCHER), 
recommend the study of organotin compounds toxicity towards the cardiovascular system.  
The present thesis is organized in five chapters: 
 Chapter 1: provides a brief introduction concerning organotin compounds, with special 
attention to tributyltin and its biological effects in mammals; 
 Chapter 2: provides a characterization of the vascular smooth muscle tissue as well as the 
regulation of contraction and relaxation; 
 Chapter 3: describes the effects of TBT in rat aorta and in the A7r5 cell line (vascular 
smooth muscle cell line obtained from embryonic rat aorta) in order to understand the 
possible impact of this compound at a vascular level; 
 Chapter 4: provides a general discussion of the results obtained and suggests future work 
in order to unravel the mechanisms that regulate TBT effects at the vascular level; 
 Chapter 5: provides the references of the thesis. 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Characterization of vascular smooth muscle tissue  
  
  
 
 21 
 
2.1 Vascular smooth muscle tissue 
 
The vascular smooth muscle is the muscular component of blood vessels which principal 
functions are the contraction and regulation of the vascular tonus, blood pressure and blood flux 
(Owens, 1995). The blood vessels are different due their physical dimensions, morphology, 
function and composition and the aspect that their all have in common is that all are lined with 
endothelial cells (Clark and Pyne-Geithman, 2005).  
Blood vessels are classified in arteries, arterioles, capillaries and veins. The blood vessels 
that are exposed to greater pressures are the arteries. Arteries are responsible to carry blood 
from the heart and therefore the arteries are thicker than other vessels and have larger 
extracellular proteins such as collagen and elastin. Arteries have an important role in the function 
of the cardiovascular system (Clark and Pyne-Geithman, 2005). 
The cells that have the responsibility to maintain the functions of smooth muscle tissue 
are the vascular smooth muscle cells (VSMC). The vascular smooth muscle cell is a highly 
specialized cell that has as primary function the contraction and relaxation of blood vessel tone-
diameter, blood pressure and blood flow distribution (Owens et al., 2004). During the vascular 
development VSMC exhibit a high rate of synthesis of extracellular matrix components such as 
collagen, elastin, proteoglycans and cadherins that comprise a major portion of the blood vessel 
mass. At this stage of development, VSMC form abundant gap junctions with endothelial cells 
which is essential for vascular maturation and vessel remodeling (Hungerford and Little, 1999). In 
adult blood vessels VSMC proliferate at an extremely low rate and have low synthetic activities. 
They  express contractile proteins, ion channels and signaling molecules that are necessary for the 
contractile function of the cells (Owens, 1995). Contrasting with the skeletal or cardiac muscle 
that are terminally differentiated, VSMC retain remarkable plasticity and can suffer profound and 
reversible phenotypic changes in response to changes in local environmental signals that normally 
regulate the phenotype (Owens, 1995). The plasticity of these cells can be seen during the 
vascular development when the VSMC plays an important role in morphogenesis of the blood 
vessels and have high rates of proliferation, migration and production of extracellular matrix 
components while acquiring contractile capabilities. In case of vascular damage these cells 
increase its rate of proliferation, migration and synthetic capacity playing a critical role in vascular 
repair (Owens et al., 2004).  
VSMC have the capacity to perform different functions which is  translated in a wide 
diversity of phenotypes, ranging from synthetic to contractile (Rensen et al., 2007). The different 
 22 
 
functions of VSMC are notable by the diversity in morphology but also in the expression levels of 
marker genes, proliferative potential and migration properties. Synthetic and contractile VSMC 
have clearly different morphologies and this is an important parameter for the definition of the 
phenotype although the use of maker proteins is also used (Rensen et al., 2007). Basically, 
synthetic VSMC are less elongated while contractile are elongated and spindle-shaped (Figure 5)  
(Hao et al., 2003; Rensen et al., 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Structural characteristic of synthetic and contractile VSMC. DP: Dense plaque; DB: Dense body; 
ECM: Extracelullar matriz; M: Mitochondria; N: Nucleus; C: Caveolae; ER: Endoplasmic reticulum; G: Golgi 
complex; CF: Contractile filaments. Figure from Rensen et al. (2007). 
 
VSMC are responsible for the vascular tone and their use is important to study several 
processes such as calcium metabolism. The entry of Ca2+ serves as a crucial intracellular 
messenger that regulates a variety of cellular processes including muscle contraction, gene 
expression, hormone secretion and neuronal transmission (Hofmann et al., 2014).  
 
2.2 Contractile proteins 
 
The contractile activity of smooth muscle is related with the contractile proteins actin and 
myosin (Webb, 2003).  Actin is  present in the thin filaments while the myosin is present in the 
thick filaments (Chamley-Campbell et al., 1979).  
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The contractile protein actin is found in all eukaryotic cells, it is a highly conserved molecule 
and has the capacity to spontaneously change from its monomeric form (G-actin) to a filamentous 
macromolecule (F-actin) (Hodgkinson, 2000). In the thin filaments of smooth muscle actin is the 
major component although tropomyosin and caldesmon are also present. The other proteins may 
be associated with the thin filaments in the cell includes filamin, vinculin, α-actinin, myosin light 
chain kinase and caldmodulin. Actin is responsible for the interaction with myosin to produce 
contraction while the other proteins modulate this interaction by imposing structural organization 
on the filaments. Thin filaments essentials functions include the force generation by interaction 
with myosin; the control of force generation by interaction with Ca2+ and the transmission of force 
to the cells to produce contraction of the muscle (Marston and Smith, 1985).  
In the thick filaments the main component is myosin II, a member of the myosin superfamily 
of motor proteins (Krendel and Mooseker, 2005).  Myosin II is a two-headed molecule consisting 
in two heavy chains and two pairs of light chains, the 20kDa (MLC20) regulatory light chains and 
the 17kDa (MLC17) essential light chains  (Gunst, 1999). The phosphorylation/dephosphorylation 
of the regulatory light chains of myosin is a key event in the regulation of smooth muscle 
contraction and relaxation. The contraction  occurs by the Ca2+ - and calmodulin-activated myosin 
light chain kinase (MLCK) and the relaxation by the myosin light chain phosphatase (MLCP) 
(Pfitzer, 2001).  
Overall, the mechanisms that regulate the behavior of the smooth muscle are based on the 
physical interactions between several structural components and the cells and their integrated 
role in mediating the transduction of chemical energy into mechanical function (Gunst, 1999). The 
main process in the generation of force and shortening of muscle cells is the cyclic crossbridge 
interaction between the thick and thin contractile filaments which contains myosin and actin, 
respectively (Arner and Pfitzer, 1999). The elevation of intracellular calcium increases the Ca2+-
bound calmodulin which in turn activates the MLCK. For the vascular muscle contraction the 
MLC20 must be phosphorylated, predominantly at serine 19,  by MLCK which results in the 
activation of the myosin MgATPase activity (Figure 6) (Stull et al., 1991). After phosphorylation 
the myosin heads  (or crossbridges) interact whit actin filaments and transport them past the 
myosin filaments (Geeves and Holmes, 1999). The energy for contraction is originated from the 
hydrolysis of ATP during the process (Arner and Pfitzer, 1999). The ending of the contractile 
stimulation causes a decrease in intracellular calcium which in turn decreases the MLCK activity. 
As a result, the MLC20 is dephosphorylated by the action of MLCP. The reversible phosphorylation 
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of MLC20 plays an important role in the regulation of the contraction of the vascular smooth 
muscle (Hirano, 2007). 
 
 
 
 
 
 
 
 
 
Figure 6. Illustration of myosin phosphorylation in smooth muscle. Schematic representation of the myosin 
molecule with two heavy chains with respective intertwined tail regions and globular head (top of the 
image). Associated with each head are the two types of light chains. The 20kDa (MLC20) regulatory light 
chain is identified by “-P” and the 17kDa (MLC17) essential light chain is shading. The pathway for initiating 
the contraction in smooth muscle is showed in the diagram. The regulatory light chain of myosin is 
phosphorylated (myosin-P) by Ca
2+
/calmodulin-dependent myosin light chain kinase and dephosphorylated 
by a protein phosphatase. The phosphorylated myosin binds to actin, resulting in increased MgATPase 
activity and contraction. Figure from Stull et al. (1991). 
 
2.3 Calcium channels 
 
The contraction of the smooth muscle starts with an increase concentration of free calcium 
in the cell cytoplasm ([Ca2+]i), which can be originated from two different sources: the 
extracellular space and the intracellular stores such as the sarcoplasmic reticulum (McFadzean 
and Gibson, 2002). Extracellular calcium enters in the cell through the ion channels and the best 
characterized calcium entry pathway is the Voltage-Operated Calcium Channels (VOCC) specially 
the L-type Calcium Channels (LTCC) (McFadzean and Gibson, 2002). However, extracellular 
calcium can enter in the VSMC through other different channels in the membrane such a: Store 
Operated Calcium Channels (SOCC); Receptor Operated Calcium Channels (ROCC); Stretch 
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Activated Calcium Channels (SACC) and Nonselective Cation Channels (NSCC) (Evans and Gelband, 
1999; McFadzean and Gibson, 2002; Setoguchi et al., 1997). 
Calcium channels (Figure 7) are complex proteins constituted by four or five different 
subunits  which are encoded by multiple genes (Catterall, 2000). The bigger subunit is the α1 with 
190 to 250 kDa that incorporates the conduction pore, the voltage sensor and gating apparatus 
and the known sites of channel regulation by second messengers, drugs and toxins. This subunit is 
organized in four homologous domains (I – IV) with six transmembrane segments in each (S1 – S6) 
(Catterall et al., 2003). Beyond this subunit there are the auxiliary subunits (β, α2δ and ɤ) that 
although they  modulate the properties of the channels, they do not have interference in the 
pharmacological and electrophysiological properties since  this originates mainly from the subunit 
α1 (Hofmann et al., 1994).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Schematic illustration of VOCCs with the different subunits. Figure from Lacinova (2005).  
The voltage operated calcium channels (VOCCs) mediate the calcium influx in response to 
membrane depolarization and regulate contraction as well as secretion, neurotransmission and 
gene expression (Catterall et al., 2003). These calcium channels are divided into two classes: the 
High-Voltage Activated (HVA) and Low-Voltage Activated (LVA) (Hagiwara et al., 1975). The Ca2+ 
currents through the HVA are activated at -40 to -10 mV whilst the currents through the LVA 
channels are activated at lower membrane potentials (-60 to -70 mV).  
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The HVA Ca2+ channels are further divided into the L-type, N-type, P/Q-type and R-type 
channels whilst LVA Ca2+ channels only have T-type channels (Figure 8). The R-type is occasionally 
classified as intermediate-voltage-activated (IVA) (Yamakage and Namiki, 2002).  
 
 
 
 
 
 
 
 
Figure 8. Dendrogram demonstrating the phylogenetic comparison of all known voltage operated calcium 
channels. HVA: High-Voltage Activated; LVA: Low-Voltage Activated; Cav1.1 to Cav3.3 are calcium channels 
subfamilies. Adapted from Lacinova (2005).  
 
The L-type Ca2+ channels are considered as long-lasting and are activated at membrane 
potentials higher than -40mV (Evans and Gelband, 1999). They are the most important ones in 
both muscular and endocrine cells and can be blocked by antagonists including dihydropyridines, 
phenylalkylamines and benzothiazepines (Catterall et al., 2003). The N-type, P/Q-type and R-type 
Ca2+ channels are expressed in neurons where they start the neurotransmission and mediate 
calcium entry into cell bodies and dendrites. The T-type Ca2+ channels are expressed in several 
cells, are activated by weak depolarization and are transient (Catterall et al., 2003). 
In the smooth muscle only two types of VOCCs exist: the L- and T-types (Xiong and Sperelakis, 
1995) and the L-type calcium channel is considered to be the principal Ca2+ influx pathway 
(Hofmann and Klugbauer, 1996). In some VSMC the influx of calcium that occurs during the 
membrane depolarization is regulated by protein kinases. The phosphorylation by cAMP-
dependent protein kinase (PK-A) or cGMP-dependent protein kinase (PK-G) inhibits the L-type 
Ca2+ channel activity and by this way produces vasodilatation, while the phosphorylation by 
protein kinase C (PK-C) stimulates the  L-type Ca2+ channel activity and thereby produces 
vasoconstriction (Xiong and Sperelakis, 1995).  
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2.4 Regulation of vascular smooth muscle contraction  
2.4.1 Ca2+- dependent contraction 
 
The activation of cell surface receptors by neurotransmitters or hormones initiates the 
contraction of vascular smooth muscle. This process can be trigged by the increase of calcium and 
is regulated mainly by the activation of the contractile proteins such as actin and myosin (Stull et 
al., 1991; Webb, 2003). In the resting state, the concentration of calcium is much lower inside the 
VSMC (i.e., 0.1µM) than in the extracellular fluid (1 – 2mM) and the activation of the contractile 
machinery requires that calcium concentration within cell exceeds approximately 1 µM (Akata, 
2007a). The concentration of cytosolic calcium is increased by the entry of calcium from the 
extracellular space through the calcium channels as well as by the calcium release from 
intracellular storage  (Webb, 2003).  
The response of the cell to the binding of the substances that act as agonists (e.g. 
norepinephrine, angiotensin, and endothelins) is to increase phospholipase C activity via coupling 
to a G protein. The phospholipase C is specific for the phosphatidylinositol 4,5-bisphosphate and 
produces two second messengers: diacylglycerol (DG) and inositol 1,4,5-trisphosphate (IP3). IP3 
binds to specific receptors on the sarcoplasmic reticulum leading to the release of calcium (Ca2+). 
Diacylglicerol with Ca2+ activates Protein Kinase C (PKC), which in turn phosphorylates specific 
target proteins.  Ca2+ binds to calmodulin causing the activation of MLCK which phosphorylates 
the MLC20. This phosphorylated MLC20 in conjunction with actin leads to  the crossbridge cycling, 
thus initiating the shortening of the smooth muscle cell (Figure 9)(Webb, 2003). 
The pathways of signal transduction involving the regulation of calcium influx or release from 
the sarcoplasmic reticulum are implicated in the increase of cytoplasmic calcium concentrations. 
In the in the smooth muscle this is the principal factor for contraction (Stull et al., 1991). The 
activity of L-type Ca2+ channels is also regulated by the sarcoplasmic reticulum and there are two 
different mechanisms for the release calcium in the smooth muscle: Ca2+ -induced Ca2+ release 
(CICR) which is activated by Ca2+ and IP3- induced Ca
2+ release (IICR) which is activated by IP3 
(Karaki et al., 1997). 
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Figure 9. Illustration of the regulation of smooth muscle contraction. Adapted  from Webb (2003). 
 
2.4.2 Regulation of the membrane potential 
 
The membrane potential is determined by the movements of ions through ion channels. 
The membrane potential together with the cytosolic calcium concentration regulates and 
modulates the influx and release of calcium through the ion channels and also the sensibility of 
the contractile machinery to calcium. The cells of the vascular smooth muscle express several 
types of channels that may be involved in the regulation of vascular tone (Jackson, 2000).  
Potassium channels are the most important pathway in vascular muscle cells to conduct 
ions  and their activity contributes to the determination and regulation of membrane potential 
and vascular tone (Jackson, 1998). The opening of K+ channels results in the diffusion of this cation 
out of the cells and consequently in membrane hyperpolarization, on the other hand, the closure 
of K+ channels has the opposite effect.  
The voltage-gated Ca2+ channel plays an important role in the regulation of vascular tone 
by membrane potential.  Their hyperpolarization closes the channels and leads to vasodilatation 
while its depolarization opens the channels and leads to vasoconstriction (Jackson, 2000).  A 
schematic representation of the regulation of vascular tone by K+ channels and voltage-gated Ca2+ 
channels is presented in Figure 10.  
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Figure 10.  Schematic illustration on K
+
 channels and their influence in the vascular tone. The opening of K
+ 
channels in the VSMC induce a diffusion of K
+
 out of the cell, causing a membrane hyperpolarization and as 
consequence the closure of voltage-gated Ca
2+
 channels, which decreases the intracellular calcium and 
consequently leads to vasodilatation. The closure of  K
+
 channels causes membrane depolarization, which  
leads to the opening of the voltage-gated Ca
2+
 channels, and therefore to an increase in the intracellular 
calcium concentrations and consequently to vasoconstriction. Figure from Jackson (2000). 
 
The chloride channels are a group of transmembrane proteins that allow Cl- movement 
across plasma membrane and intracellular organelles (Servetnyk and Roomans, 2007). These 
channels have been also described as regulators of the vascular tone and their opening results in 
efflux of Cl- from the vascular cells. Due to the  Cl- negative charge this efflux induces 
depolarization and vasoconstrion whilst the closing Cl- channels have the opposite effect (Jackson, 
2000). 
 
2.4.3 Ca2+- independent contraction  
 
The Ca2+- dependent contraction is not the only contraction mechanism in the smooth 
muscle, the cytoplasmic calcium concentration is further modulated by the Ca2+ sensitivity of the 
Ca2+ sensors (Somlyo and Somlyo, 2003). As explored above, the mechanism for contraction is 
through the phosphorylation/dephosphorylation of the regulatory light chain of myosin II MLC20. 
The activation of MLCK by Ca2+ binding to calmodulin (CaM) leads to phosphorylation of the MLC20 
to switch on crossbridge cycling and force contraction (Stull et al., 1991). The ratio between the 
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MLCK and MLCP activities determines the level of MLC20 phosphorylation. In situations of 
continuous stimulation, there is a reduction in the Ca2+ concentrations and in the amount of 
phosphorylated MLC20, whilst the isometric strength increases. This suggests that non 
phosphorylated myosin is also involved in the maintenance of contraction. Thus, Ca2+-
independent modulation of the MLCK and/or MLCP activities provides additional mechanisms for 
the regulation of MLC20 phosphorylation (Somlyo and Somlyo, 2003). This mechanism generally 
known as calcium sensitization, is calcium independent being responsible for the alteration in the 
contractility even in the presence of constant concentrations of calcium.  
The Ca2+ sensitization can be regulated either by the MLC20 phosphorylation-dependent or –
independent mechanisms, however, the phosphorylation-dependent mechanism is considered to 
play the major role (Hirano, 2007).   
The MLCP inhibition may occur through two different pathways: RhoA/Rho-kinases  with 
phosphorylation of myosin phosphatase targeting subunit-1 (MYPT1) and/or PKC with PKC-
potentiated phosphatase inhibitor (CPI-17) (Mizuno et al., 2008).  In the first pathway Rho-kinases 
phosphorylates MYPT1 leading to the inhibition of MLCP activity in the smooth muscle; in the  
other pathway the activation of PKC phosphorylates the CPI-17 witch also potentiates the 
inhibition of the MLCP activity (Mizuno et al., 2008).  
The modulation of Ca2+ sensitivity is not limited to the phosphorylation of MLC20 and can be 
also mediated by other mechanisms (Somlyo and Somlyo, 2003). The mitogen-activated protein 
(MAP) kinase is one of those mechanisms  involved in the Ca2+-independent smooth muscle 
activation (Dessy et al., 1998). MAP kinases are regulated by phosphorylation cascades and 
contains at least three protein kinases in series that culminate in the activation of a 
multifunctional MAP kinase (Pearson et al., 2001). 
 
2.5 Regulation of vascular smooth muscle relaxation 
 
 
The smooth muscle relaxation occurs when the contractile stimulus stops or by the direct 
action of a substance that stimulates the inhibition of the contractile. However, a reduction in the 
intracellular concentration of Ca2+ and a increase of MLCP activity are necessary for the smooth 
muscle relaxation (Webb, 2003).  
The process of relaxation is the opposite of the contraction process and ends with the return 
to Ca2+ basal levels. When cytosolic calcium concentration is lower than 1µM the 
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dephosphorylation of MLC20 by MLCP occurs and consequently the inactivation of MLCK. The 
complex Ca-CaM-MLCK is dissociated and as a result the Ca2+ that was bounded to CaM is released 
(Arner and Pfitzer, 1999). There are, however, other ways to decrease cytosolic calcium 
concentrations including, for example the plasma membrane Ca2+-ATPase (PMCA) pump; the SR 
Ca2+-ATPase (SERCA) pump; the Na+/Ca2+ exchanger (NCX) and the cytosolic Ca2+ -binding proteins 
(Akata, 2007a). PMCA and SERCA pumps are believed to play an essential role in reducing the 
cytosolic calcium levels during the resting condition and/or in mediating the vasodilator action of 
several endogenous agents. Under physiological conditions, the reduction of cytosolic calcium 
occurs mainly by the transference of Ca2+ into the extracellular space mediated by  PMCA or by 
the uptake of Ca2+ into SR intracellular stores mediated by SERCA (Akata, 2007a).  
The Na+/Ca2+ exchanger (NCX), located on the plasma membrane, also plays a significant role 
in the regulation of [Ca2+] (Juhaszova et al., 1996).  
Besides these mechanisms that reduces the concentrations of intracellular calcium in the 
VSMC, the inhibition by antagonists of the receptor-operated and voltage-operated Ca2+ channels 
located in the plasma membrane also inhibit Ca2+ entry in the smooth muscle cells and elicit 
relaxation (Webb, 2003). 
The vasodilatation under physiological conditions is also regulated by the cyclic nucleotides 
cAMP and cGMP which are considered as key messengers in this process. The intracellular levels 
of these messengers are the result of the balance between the rate of their synthesis and the rate 
of their degradation (Morgado et al., 2012). In VSMC the elevation of both cAMP and cGMP are 
related with relaxation of smooth muscle tissue in response to several vasodilators (Xiong and 
Sperelakis, 1995).  
The cyclic AMP is synthesized from intracellular ATP by adenylate cyclases which are normally 
activated by external stimulus (neurotransmitters, hormones or drugs) that binds to a G-protein-
coupled receptor (Willoughby and Cooper, 2007).  
The cyclic GMP in the VSMC may be synthesized by two guanylate cyclases that differ in their 
cellular localization and activation: the particulate guanylyl cyclase (pGC) that is present in the 
plasma membrane and that is activated by natriuretic peptides (Potter et al., 2006) and the 
soluble guanylyl cyclase (sGC) that is activated by nitric oxide (NO) and by NO donors (Cary et al., 
2006). The intracellular levels of both these cyclic nucleotides can be degraded to their 
biologically inactive metabolites by phosphodiesterases (Omori and Kotera, 2007). 
The actions of cAMP and cGMP are usually attributed to activation of the protein kinase A 
(PKA) and protein kinase G (PKG) respectively (Morgado et al., 2012). It is well established that an 
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increase in the cytosolic level of cAMP and cGMP in the VSMC is one of the main mechanisms for 
relaxation, however the mechanism is not yet fully understood and it seems to vary between 
different blood vessels, species and also to be dependent on the stimulus (Morgado et al., 2012). 
Several pathways have been proposed by different authors to explain the vasodilator effect of 
cyclic nucleotides (Akata, 2007b; Cogolludo et al., 2007; Karaki et al., 1997; Lincoln et al., 2001; 
Martel et al., 2010; Orallo, 1996; Rembold, 1992; Woodrum and Brophy, 2001). These pathways 
can be summarized as follows: 
1) The reduction of [Ca2+]i that can be achieved by the activation of Ca
2+ uptake by the 
SR, increased intracellular Ca2+ efflux, inhibition of Ca2+ release from the SR and/or 
decreased extracellular Ca2+ influx; 
2) The hyperpolarization of the membrane potential through activation of potassium 
channels, inactivation of Na+ channels and/or inactivation of multiple channels; 
3) The decrease in the sensitivity of the contractile machinery by the reduction of the 
[Ca2+]i sensitivity of MLC20 phosphorylation due to a decrease in the MLCK activity 
and/or to an increase of the MLCP activity; 
4) The decrease in the sensitivity of the contractile machinery through uncoupling from 
MLC20 phosphorylation via a thin-filament regulatory process. 
 
Moreover, each cyclic nucleotide can also activate both the protein kinases, PKA and PKG. The 
PKA can be activated by cGMP but it requires a 10-fold-higher cGMP concentration than cAMP. 
Similarly, the PKG can be activated by cAMP although it requires a 10-fold-higher cAMP 
concentration than cGMP. In the smooth muscle, the levels of cytosolic cAMP are normally nearly 
10-fold higher than the cGMP levels which means that elevations in the cytosolic level of cAMP 
could activate both PKA and PKG but cGMP only activates PKG (Rembold, 1992). 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Evaluation of TBT effects in the contractility of rat artery and in the L-type 
calcium channels  
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3.1 Introduction 
 
Tributyltin (TBT) is one the most studied organotin compounds, with several described 
adverse effects towards a wide range of organisms, including humans. This compound was used 
for decades as active biocide in antifouling paints and it was responsible for a massive 
contamination of the aquatic environment (Sousa et al. 2014a). It acts as a potent endocrine 
disruptor (Sousa ACA et al., 2013), being  also considered as a model obesogen due to its ability to 
inappropriately activate the master nuclear receptor of adipogenesis (PPAR) and therefore to 
influence the development of obesity (Pereira-Fernandes et al., 2013). TBT is also considered to 
be immunotoxic (Hendriksen et al., 2014), neurotoxic  (Mitra et al., 2013) and is also able to 
interfere with the cardiovascular system of mammals (Nath, 2008). 
Besides being used as biocides, organotin compounds were also used as plastic stabilizers, 
catalytic agents for the production of polyurethane foams and silicones, pesticides and glass 
coatings. Due to their toxicity, the use of organotins is regulated in European Union (Decision 
2009/425/EC, Regulation Nº276/2010 and Annex XVII of REACH, 2010). Accordingly, the majority 
of organotin compounds (TBT, TPT and DOC) had their effective ban in the 2012, whilst DBT 
effective ban only entered into force in the 1st January 2015 (see Sousa ACA et al., 2013 for a 
complete description of EC regulations on OTs). Despite the fact that organotins are already 
banned, the widespread contamination of the maritime environment (and consequently seafood), 
and their ubiquitous occurrence in consumer products  grants them a constant presence in our 
everyday life and therefore humans may be exposed to TBT and other organotin compounds on a 
regular basis. 
Currently, besides diet (particularly seafood from highly polluted locations), house dust is 
considered to be the most important pathway to human exposure to organotins, particularly TBT 
(Sousa et al., 2014; Kannan et al., 2010; Fromme et al., 2005). However, in specific groups of the 
population there is also concern of continuous exposure to OTs through medical devices (SCHER, 
2006). This concern is based on the fact that organotins were employed (at least until 1st January 
2015) as catalytic agents in production of silicones used in several medical devices such as breast 
implants, silicone valves, tubes and bags (SCHER, 2006). A couple of breast implants, for example, 
may contain one kg of silicone, if this silicone contains 0.1% of organotins it would represent 1 
gram of OTs in the implants which may give a person of 70kg the tolerable daily intake 
(considering an emission factor as low as 0.000007) (SCHER, 2006).  
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Taking this into account, regulatory agencies including the Scientific Committee on Health 
and Environmental Risks (SCHER), recommend the study of organotin compounds toxicity (RPA, 
2005; SCHER, 2006). Furthermore, several reports demonstrated interferences of organotins in 
the cardiovascular system (Cameron et al., 1991; Nath, 2008). Studies using rodent models 
associated TBT to cardiovascular disorders (Nath, 2008), however general consensus on the 
effects of TBT is far from being reached. Some studies demonstrated that  TBT impairs the 
coronary vascular reactivity response to estradiol, produces endothelial denudation in isolated rat 
hearts (dos Santos et al., 2012) and has the capacity to decrease smooth muscle actin protein 
expression in aortic rings in rats  (Rodrigues et al., 2014). It also  induces endothelial dysfunction 
and collagen deposition (Rodrigues et al., 2014). Recently, the effect of TBT on mammalian 
endothelial cell integrity was studied and it was demonstrated that this compound deeply alters 
the endothelial profile (Botelho et al., 2015). 
Based on the limited knowledge of TBT effects in the vascular system and on the 
recommendations of the  European Commission through the Scientific Committee on Health and 
Environmental Risks (SCHER) to further study the impacts of organotins that may be found in 
heath devices, including the ones used to treat  cardiovascular pathologies (e.g. cardiac valves), 
the present study aims to  elucidate the effect of TBT  in the contractibility of rat artery and its 
effects on the L-type calcium channels in A7r5 cells in order to understand the possible impact of 
TBT in vascular cells.  
 
3.2 Methods 
 
 
All the laboratory work was performed at the physiology laboratory of the Health Sciences 
Research Centre (CICS-UBI), University of Beira Interior.   
 
3.2.1 Contractility Experiments  
3.2.1.1 General principle of the organ bath technique 
 
The organ bath assay (Figure 11) is a classical pharmacological tool for the evaluation of 
concentration-response relationships in several isolated section of contractile organs or tissues 
(McCallum et al., 2014). The principal characteristic of this technique is the ability to measure 
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concentration-dependent changes and to test the efficacy and potency of contractile agonists that 
can be manipulated by increasing concentrations of antagonists or inhibitors  (Jespersen et al., 
2015). An important characteristic of this technique is that because the tissue is alive it functions 
as a whole tissue maintaining physiological outcomes (e.g. contraction or relaxation) that are 
relevant to the body (Jespersen et al., 2015). Another important advantage is that because this 
technique is a synthesis of several steps, e.g. drug-receptor interactions, signal transduction, 
second messenger generation, change in smooth muscle excitability and change in tissue 
function; it allows the integrated study of all these steps contrarily to other techniques that only 
allow a single step characterization (Jespersen et al., 2015). Furthermore, this technique by being 
real time allows rapidly drawing conclusions, planning next steps, and troubleshooting during the 
experiment. Despite these advantages, this assay has several limitations mainly related with the 
protocol for sample preparation. In fact, there is the possibility that during surgical removal or 
during the placement of the tissue rings in the hooks, the tissues can be damaged so this is a 
critical step and careful handling of the tissue is required (Jespersen et al., 2015). 
 
 
 
 
 
 
 
Figure 11. Organ bath system (a) Picture of the system used (b) schematic representation of the system. 
Adapted from Yildiz et al, 2013.  
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3.2.1.2 Rat Aorta Contractility Experiments 
3.2.1.2.1 Experimental animals and rat thoracic aorta rings isolation 
 
Male adult Wistar rats (Charles-River, Barcelona, Spain) weighing 400-500 g were 
sacrificed by decapitation and, after thoracotomy, and the thoracic aortas were removed, placed 
in a thermostatized (37ºC) Krebs modified solution following the standard protocol used in the 
physiology laboratory (Cairrão et al., 2012). The composition of Krebs modified solution was 
(mmol/L):  NaCl 119, KCl 5, CaCl2●2H2O 2.5, MgSO4●7H2O 1.2, KH2PO4 1.2, NaHCO3 25, EDTA-
Na2 0.03, L-(+)-ascorbic acid 0.6 and glucose 11 (pH 7.4). The concentration of calcium (2.5 mM) 
in the krebs modified solution used was based on the one previously described in similar studies 
(Carre et al., 2015; Rodrigues et al., 2014). The fat and connective tissue were cleaned and 
vascular endothelium was mechanically removed by gentle rubbing with a cotton bud introduced 
through the arterial lumen as fully described by Alvarez et al. (2010).  
The animals used in the current experiment (n=5) were acclimatized for at least one week 
before the beginning of the experiments under light cycles of 12h light: 12h dark; with food and 
water ad libitum. The experiments were conducted in compliance with the protocols approved by 
the National Ethics Requirements for Animal Research (Decreto-Lei nº 113/2013, de 7 de Agosto) 
and European Convention for the Protection of Vertebrate Animals Used for Experimental and 
Other Scientific Purposes (European Union Directive number 2010/63/EU). 
 
3.2.1.2.2 Artery tension recordings 
 
The evaluation of the artery tension was performed following the standard protocols 
routinely used in the physiology lab (e.g. Cairrão et al., 2012) using in the same artery ring two 
different contractile agents: Noradrenaline (NA) and Potassium Chloride (KCl) (see Figure 12).  
These two chemicals induce contraction by different mechanisms: NA through direct binding to 
membrane receptors and KCl by membrane depolarization.  
The rat aorta artery rings were placed in the organ bath (LE01.004, Letica) containing 
Krebs-bicarbonate solution at 37ºC continuously gassed with carbogen. The rings were suspended 
by two parallel stainless steel wires and tension measurement was performed using isometric 
transducers (TRI201, Panlab SA, Spain), interface PowerLab/4SP (ML750, ADInstruments), and 
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computerized system with Chart5 PowerLab software (ADInstruments). In the resting periods the 
organ bath solution was changed every 15 minutes.  
Firstly, the rings were equilibrated for 60 minutes until a resting tension of 1.0 g. After this 
equilibrium period, the aortic rings were firstly contracted with noradrenaline (NA) at 1µM and 
the absence of endothelium functionality was confirmed by the lack of relaxant response to 
acetylcholine (Ach) at 1µM.  
The arteries were then washed for 15 min three times with Krebs modified solution 
before the next stimuli. The rings were then contracted using noradrenaline (NA) at 1µM. When 
the maximum contraction was reached the effects of TBT on this contraction were analyzed. For 
this purpose, TBT solutions (0.1nM, 1nM, 10nM, 100nM, 1x103 nM, 1x104 nM and 1x105 nM) were 
added sequentially. The artery rings and the system were then thoroughly washed with Krebs 
modified solution (3 times during at least 15 min each time). Afterwards, another contractile 
agent - potassium chloride (KCl) at 60mM - was added and the effects of TBT on this contraction 
were again analyzed by sequentially adding increasing concentrations of TBT. Control experiments 
were always performed in parallel using the same amount of ethanol used to prepare each TBT 
experimental solution. The concentration of EtOH was below 0.01% (v/v) in all experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. Schematic representation of the organ bath technique. The top panel represents the 
experimental preparation of the artery rings, since the removal of the aorta from the rats until the 
placement of the aortic rings in the organ bath. The bottom panel represents the different steps performed 
in order to evaluate: (1) the absence of endothelium; (2) the effects of TBT on the vasoconstriction induced 
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by noradrenaline (NA); (3) the effects of TBT on the vasoconstriction induced by potassium chloride (KCl); 
(4) the effects of TBT on the basal state. For each experiment a parallel experiment with a different artery 
ring was performed using ethanol, the solvent used to prepare TBT experimental solutions with the exact 
same conditions. All of the compounds are applied directly into the organ chamber without disturbing the 
tissue. 
 
3.2.2 Electrophysiological Experiments  
3.2.2.1 Cell culture 
3.2.2.1.1 A7r5 cell line 
 
The A7r5 cells are a commercial cell line derived of vascular smooth muscle obtained from 
embryonic rat aorta (Obejero-Paz et al., 1998b).  This cell line has been extensively used as a 
model to study calcium homeostasis in vascular cells (Karaki et al., 1997) because A7r5 cells 
express the same voltage-dependent and receptor-activated calcium channels observed in freshly 
isolated smooth muscle cells from rat aorta (Marks et al., 1990) and the kinetics of Ca2+ 
mobilization is similar to that of differentiated smooth muscle cells (Lapidot et al., 1996). 
Furthermore, A7r5 cells also exhibit structural and functional properties of vascular smooth 
muscle (Marks et al., 1990).  
In A7r5 cells the pathway of Ca2+ influx is voltage sensitive. This Ca2+ influx is a consequence of 
the activity of specific channels. It was demonstrated by the measurement of currents in the 
whole cell configuration of the patch clamp technique that these currents are due to the opening 
of L-type calcium channels (Marks et al., 1990; Obejero-Paz et al., 1998a). It was also 
demonstrated that the whole cell calcium currents recorded from these cells are often an order of 
magnitude greater than those recorded from freshly isolated vascular smooth muscle (Marks et 
al., 1990). Besides these advantages, large amounts of cells can be conveniently grown in the 
laboratory which enables to perform electrophysiology studies in parallel.  
3.2.2.1.2 A7r5 cell culture 
 
The A7r5 cell line used is a commercial cell line purchased from Promochem (Spain). The 
cells were grown in the culture medium Dulbecco Modified Eagle Medium/Nutrient Mixture F-12 
Hams (DMEF-F12; Sigma-Aldrich, Portugal) supplemented with NaHCO3 (1.2 µg/L), L-ascorbic acid 
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(20 µmg/L; Sigma-Aldrich), bovine serum albumin (0.5%; Sigma-Aldrich), heat-inactivated fetal 
bovine serum  (FBS - 10%; Biochrom), and a mixture of penicillin (100 u/mL), streptomycin (100 
g/mL) and amphotericin B (250ng/mL; Sigma-Aldrich). The cells were kept in culture at 37ºC in an 
atmosphere of 95% air and 5% CO2. The culture medium was changed every 2-3 days.  
After confluence, the cells were placed in culture medium without FBS (FBS-free culture 
medium) for 24 hours. Trypsinization was performed and the cells were kept at 4ºC in FBS-free 
medium until the electrophysiological experiments (Alvarez et al., 2010). 
 
3.2.2.2 Electrophysiological Experiments – Patch Clamp 
3.2.2.2.1 Patch Clamp general principle 
 
The patch clamp is a technique that allows the investigation of currents flowing through 
ion channels in several types of cells such as VSMC (Neher et al., 1978). This technique that 
measures ionic currents under voltage-clamp, was designed to study small patches of membrane 
in which near-perfect control of the transmembrane voltage can be readily achieved. Channel 
activity results in modifications of membrane conductance and this can be conveniently evaluated 
by recording membrane currents at a constant membrane voltage (Sontheimer and Ransom, 
2002).  
To perform patch clamp a small glass pipette is polished by heat and afterwards it is 
pressed against the cell membrane, forming a “seal” between the electrical surface of the pipette 
and the cell membrane (Figure 13). The application of a negative pressure inside the micropipette 
causes an increase in resistance of the “seal”, which is designated a giga-ohm seal (resistance 
>10GΩ). A high seal resistance is necessary because the higher the seal resistance, the more 
complete is the electrical isolation of the membrane patch and a high seal resistance decreases 
the current noise of the recording which permits a good time resolution of channel currents 
(Ogden and Stanfield, 1994). The cell-attached configuration allows the ionic current to flow 
through the open channels of the electrically isolated portion of the membrane to the 
micropipette. The “seal” that is formed is mechanically stable and thus it is possible to perform 
several settings for the study of ion channels (Neher et al., 1978).  
 42 
 
 
 
 
 
 
 
 
Figure 13. Illustration with the general principle of the patch clamp technique. A glass pipette that contains 
electrolyte solution is tightly sealed onto the cell membrane and thus isolates electrically the membrane 
patch. The currents fluxing through the channels in this patch flow into the pipette and can be recorded by 
an electrode that is connected to a highly sensitive differential amplifier. Figure from http://www.leica-
microsystems.com/science-lab/the-patch-clamp-technique/.  
 
Different configurations can be used in the patch clamp technique (Figure 14) depending 
on the research interest. The configuration most commonly used for cell culture and tissue 
preparations is the whole-cell mode (Zhao et al., 2008). With this method the patch created in the 
cell-attached is ruptured with a pulse of suction or voltage, thus establishing low electrical 
resistance and physical continuity between the cell and the pipette. The access to the cell interior 
allows the voltage of the whole cell to be controlled via a voltage clamp. It is possible to observe 
the currents from all the ion channels in the cell membrane and also to separate the individual 
current types by controlling the chemical composition on both sides of the cell membrane (Zhao 
et al., 2008).   
 
 
 
 
 
 
 
 
 43 
 
Figure 14. Illustration of the four different configurations for the patch clamp technique. Cell-attached: 
when the pipette is in closest proximity to the cell and mild suction is applied to gain a tight seal between 
the pipette and the membrane. Whole-cell: by applying a brief but strong suction the cell membrane is 
ruptured and the pipette gains access to the cytoplasm. Inside-out: when in the cell-attached mode the 
pipette is retracted and the patch is separated from the rest of the membrane and exposure to air. Outside-
out: when in the whole-cell mode the pipette is retracted resulting in two small pieces of membrane that 
reconnect and form a small vesicular structure. Figure from http://www.leica-microsystems.com/science-
lab/the-patch-clamp-technique/.  
 
3.2.2.2.2 L-types calcium channels current  measurement 
 
The electrophysiological experiments were performed following the standard techniques 
routinely used in the physiology lab and fully described in Alvarez et al. (2010).  
All experiments were performed at room temperature (23±2ºC). The patch clamp technique 
in the whole-cell configuration was used to analyze the effect of different TBT concentrations in 
calcium current thought the LTCC (ICa,L) in A7r5 cells. This study was performed over the basal 
calcium current without any stimulus. The basal current amplitude was measured 3 to 5 minutes 
after patch break to allow the equilibration between the pipette and the intracellular solutions. 
The composition of the control external solution in which cells were maintained during the period 
of the experiment and also used as control was (mM): NaCl 124.0, CaCl2 5.0, HEPES 5.0, 
tetraethyllammonium sodium salt (TEA) 10.0, KCl 4.7, and glucose 6.0 with a   pH of 7.4 adjusted 
with NaOH.  The solution inside the patch electrodes (2-4MΩ) -  internal solution - had the 
following composition (mM) : CsCl 119.8, CaCl2 0.06, MgCl2 4.0, Na-ATP 3.1, Na-GTP 0.4, EGTA 5.0, 
HEPES 10.0, and TEA 10.0, with a pH of 7.3 adjusted with CsOH.  
The cells were maintained in the petri dish with the control external solution at a holding 
potential of -80 mV and routinely depolarized every 8s to 0mV during 500 ms. The cells were 
voltage clamped with the patch electrolyte filled with internal solution using the patch-clamp 
amplifier Axopatch 200B (Axon instruments, USA). Currents were sampled at a frequency of 10 
kHz and filtered at 0.1 kHz using the analog-digital interface Digidata 1322A (Axon Instruments, 
USA) connected to a compatible computer with the Pclamp8 software (Axon Instruments, USA). 
For each individual cell the effects of the different concentrations of TBT (0.1nM, 1nM, 10nM, 
100nM, 1x103 nM, 1x104 nM and 1x105 nM) were tested by transferring the cell from the external 
solution into the inside of capillaries filled with the TBT testing solutions (Figure 15 and 16). In 
between each TBT concentration the cell was washed in control external solution. A similar 
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procedure was performed for EtOH using the same final volume of ethanol as the one used to 
prepare TBT experimental solutions (7.18x10-9 to 7.18x10-3 % v/v). 
The variations induced by the different TBT concentrations and their respective solvent 
controls in the basal Ica,L are expressed in percentage. 
 
Figure 15. Patch clamp equipment (a) Picture of the equipment installed inside a Faraday cage; with the 
detail of the capillaries filled with the testing solutions (b) where the cells will be exposed (c).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16. Schematic illustration of the steps to perform the patch clamp technique. Firstly, the basal state 
of the cell is measured in the control external solution. Secondly, the lowest TBT concentration (0.1nM) is 
tested, the effect in the calcium current is registered and after that the cell returns to the control external 
solution. Next, the increasing TBT concentrations are tested and between all TBT concentrations tested, the 
cell always returns to the control external solution. Ethanol, the solvent used to prepare the TBT 
experimental solutions, was tested in different cells following the exact same procedure. Figure from 
http://www.the-scientist.com.  
 
3.3 Test solutions 
 
A stock solution (1M) of tributyltin chloride (TBTCl – Aldrich, 96%) was prepared in absolute 
ethanol (Analytical grade, Fisher Chemicals). Experimental solutions (0.1nM, 1nM, 10nM, 100nM, 
1x103 nM, 1x104 nM and 1x105 nM) were freshly prepared every day in Krebs modified solution for 
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organ bath experiments or in control external solution for patch clamp experiments. Final 
concentrations of ethanol all experimental solutions never exceeded 0.01%. 
 
3.4 Data Analysis 
 
In the contractility experiments, the relaxant response induced by TBT (or ethanol) is 
expressed as a percentage of the maximal contraction (Emax= 100%) produced by the 
corresponding vasoconstrictor agent (NA or KCl). In the electrophysiological experiments the ICa,L 
amplitudes were automatically calculated between the maximum current peak and the stable 
current plateau near the final of every 8s pulse. The variations induced by TBT are expressed as 
percentage. All results are expressed as mean ± standard error (SEM) of n experiments. In the 
contractility experiments n is the number of rings used and in the electrophysiological 
experiments n is the number of cells analyzed.  Statistical analyses were performed using 
SigmaPlot 11.0 software. Comparison between each TBT concentration and its respective EtOH 
control was performed using Students t-test and Mann-Whitney Test (nonparametric test). 
Comparisons between the groups were performed using One Way ANOVA followed by Tukey post 
hoc test. Probability levels were considered significant when lower than 5% (p<0.05).  
 
3.5 Results 
3.5.1 Effects of TBT on rat aorta contractility 
 
 The administration of Ach (1µM) in the contracted artery rings didn’t induce any relaxant 
response (mean tension value: -2.95±0.87 mg; n=19). This absence of relaxant response confirms 
the absence of endothelium in all the aortic rings used in the experiments. 
The rat aortic rings without endothelium were contracted with two different contractile 
agents: NA (1µM) and KCl (60mmol/L). The contraction elicited by NA (1478.1 ± 141.7 mg; n=20) 
in rat artery rings was not significantly different (t-test, p= 0.696) from the one induced by KCl 
(1548.1 ± 115.5 mg; n=27). 
No significant differences in the tension induced by NA (1µM) were registered in any of the 
different EtOH concentrations tested (7.18x10-9 to 7.18x10-3) (one way ANOVA, p=0.574). TBT 
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induced relaxation (expressed as negative tensions, see Figure 17) after NA (1µM) contraction at 
all concentrations tested except for the lowest one (0.1nM) where a small contraction was 
registered (0.66%). The relaxation induced by TBT at all other concentrations was very low with a 
maximum relaxation of only  17.9% registered at the highest TBT concentration tested   (1x105 
nM) (Figure 17). This maximum effect at the highest concentration of TBT tested was also 
observed at its respective control (Figure 17) although to a lesser extent. In fact, the variation in 
tension induced by TBT was never significantly different from its respective EtOH controls (t-test, 
p>0.05). Significant differences in tension were found between the highest TBT concentration 
tested (1x105 nM) and the following TBT concentrations 0.1nM (Tukey test, p=0.001), 1nM (Tukey 
test, p=0.004), 10nM (Tukey test, p=0.009) and 100nM (Tukey test, p=0.011). 
Figure 17. Effects of TBT (n=8) and respective EtOH control (n=5) on rat artery rings contracted by NA 
(1µM). The response induced by TBT (or ethanol) is expressed as a percentage of the maximal contraction 
(Emax= 100%) produced by NA. Negative tension values indicate relaxation whilst positive ones indicate 
contraction. Tension values with the same letter are significantly different. (p<0.01, Tukey test). 
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No significant differences in the tension induced by KCl (60mmol/L) were registered in any 
of the different EtOH concentrations tested (7.18x10-9 to 7.18x10-3) (one way ANOVA, p=0.517). 
TBT induced relaxation (expressed as negative tensions, see Figure 18) after KCl (60mmol/L) at 
levels higher than the ones reported for NA. In fact, except for the lowest TBT concentration 
tested (0.1nM) the percentages of relaxation were always higher than 14%, with the highest value 
reaching 33%. This maximum relaxation was reached with the highest TBT concentration tested 
(1x105 nM). Despite this, the relaxations were still low and with no significant differences between 
their respective EtOH control (t-test/Mann Whitney t-test, p>0.05).  No significant differences in 
tension could be found between the different TBT concentration tested (one way ANOVA, 
p=0.097). 
Figure 18. Effects of TBT (n=9) and respective EtOH control (n=6) on rat artery rings contracted by KCl (60 
mmol/L). The response induced by TBT (or ethanol) is expressed as a percentage of the maximal contraction 
(Emax= 100%) produced by KCl). Each value represents the mean of the % of tension ± SEM from the number 
of experiments. No significant differences were found between the different TBT concentrations.  
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Figure 19 shows the comparison of TBT relaxant effects in arteries contracted with NA 
(1µM) and KCl (60mmol/L). Overall, TBT relaxant effects were low for both contractile agents, 
never reaching 50% of contraction (in fact the highest value was 33%). Significant differences 
between the two contractile agents were only detected between the relaxation induced by NA 
and KCl at TBT concentrations 1nM,  1x103 nM and 1x104 nM.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19. Comparison of the effects of TBT on the contraction induced by NA (1µM) (n=8) and KCl 
(60mmol/L) (n=9). The response induced by TBT is expressed as a percentage of the maximal contraction 
(Emax= 100%) produced by Na or KCl. Negative tension values indicate relaxation whilst positive ones 
indicate contraction. Tension values with the same letter are significantly different (t-test, p<0.05). 
The effects of TBT and respective solvent controls on the basal tension of rat aorta without 
the addiction of any contractile agent, were also analyzed (Table 3). The obtained results 
demonstrate that TBT doesn’t have a contractile effect with a maximal tension recorded of about 
72 mg, far below the real tension for a contractile agent (1000 mg).  Similar results were obtained 
for the EtOH control with a maximum tension approximately 10 folds lower that the typical 
tension of a contractile agent.  
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Table 3. Real tension (mg) of TBT (0.1 - 1x10
5
nM) and their respective solvent control. Each value 
represents the real tension (mg) ± SEM of the number of experiments (n). (*) The final percentages of EtOH 
are the same as the ones used in the preparation of the corresponding TBT experimental solution (varying 
from 7.18x10
-9
 to 7.18x10
-3
 and thus never exciding 0.01%). 
 
 Real tension (mg)  
TBT 
Concentration 
TBT EtOH(*) 
0.1 nM -13.25 ± 37.37 (n=8)  65.43 ± 46.30 (n=7) 
1 nM 29.75 ±25.99 (n=8) 128.71 ± 81.42 (n=7) 
10 nM 10.75 ± 14.29 (n=8) 91.86 ±59.25 (n=7) 
100 nM 31.38 ± 24.04 (n=8) 80.43 ±64.33 (n=7) 
1x103 nM 22.88 ± 17.74 (n=8) 65.43± 63.56 (n=7) 
1x104 nM 16.50 ± 16.04  (n=8) 86.14 ± 63.29  (n=7) 
1x105 nM  71.75 ± 24.34  (n=8)  102.29 ± 70.67 (n=7) 
 
 
3.5.2 Effects of TBT on L-type calcium channels of A7r5 cells 
 
The effects of TBT and EtOH control on the inhibition of ICa,L are depicted in Figure 20. 
Similarly to what was observed for contractility experiments with rat artery rings, no significant 
differences were registered in the inhibition of ICa,L in A7r5 cells with any of the different EtOH 
concentrations tested (7.18x10-9 to 7.18x10-3) (one way ANOVA, p=0.577).  
The maximum inhibition of ICa,L was observed at 1 nM of TBT with almost 15% of inhibition 
and the minimum was detected at 1x103 nM with 1% of inhibition. The maximum inhibition was 
not observed for the highest TBT concentration and the same is true for the lowest inhibition.  
The obtained results demonstrate that TBT inhibits the ICa,L at very low levels (1% to 14%) 
and with no significant differences between the TBT concentrations tested and their respective 
controls (t-test, p>0.05) and with no significant differences within the different TBT 
concentrations tested (one way ANOVA, p=0.074).  
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Figure 20. Effects of TBT and respective solvent control in the inhibition of ICa,L in A7r5 cell line. The ICa,L 
amplitudes were automatically calculated between the maximum current peak and the stable current 
plateau near the final of every 8s pulse. The variations induced by TBT or EtOH are expressed as percentage. 
Each column represents the mean value ± SEM from the number of experiments.  
 
3.6 Discussion 
 
 
According to the World Health Organization the cardiovascular diseases are the number 
one of death globally (WHO, 2015) and recent reports suggest that exposure to environmental 
contaminants may play a role in the etiology of cardiovascular diseases (Cosselman et al., 2015). 
Organotins are an important class of environmental contaminants for which limited and 
sometimes contradictory information on their effects into the cardiovascular system is available 
(e.g. Nath, 2008). Since organotins are used as catalysts in the production of silicones and  
medical devices that are made with silicone such as breast implants, tubes and bags, may contain 
organotins in their constitution, the regulatory agencies including the Scientific Committee on 
Health and Environmental Risks, recommend the study of organotin compounds toxicity towards 
humans (SCHER, 2006). In order to provide further evidences on the effects of TBT on the vascular 
system we investigated TBT effects on contractility of rat aorta using the organ bath technique 
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and on the L-type calcium channels analyzed by the whole-cell configuration of the patch clamp 
technique.  
The results from the contractility experiments disclose that TBT had low effect of the 
vasoconstriction induced either by Na or KCl, the two contractile agents used in the present work.  
At first, the absence of endothelial cells was confirmed by the lack of relaxant response to 
acetylcholine in the NA contraction (about 3% of relaxation). It is well established, based on 
pharmacological evidences, that acetylcholine is able to induce relaxation in aortic tissues 
contracted by NA with intact endothelium but unable to relax these tissues without endothelium. 
Therefore, when endothelium is removed the relaxant response to acetylcholine is completely 
lost (Perusquia et al., 1996). Acetylcholine that is a neurotransmitter, when released by nerve 
terminals in the blood vessels wall activates the nitric oxide (NO) synthase in endothelial cells 
leading these cells to produce NO from arginine. The NO diffuses rapidly across membranes and in 
the smooth muscles cells it binds and activates guanylyl cyclase to produce cyclic GMP. The cyclic 
GMP triggers a response that causes the smooth muscle cells to relax (Alberts et al., 2008). 
As previously mentioned, in this work two different contractile agents (NA and KCl) were 
used to induce contraction on the rat aorta rings without endothelium. These two agents were 
selected based on the fact that they illicit contraction trough different mechanisms. The calcium 
movements in the smooth muscle can occur by two different Ca2+ influx pathways: receptor-
linked and voltage-dependent Ca2+ channels. The receptor-linked Ca2+ channels are opened by the 
release of Ca2+ from the sarcoplasmic reticulum induced by NA. In contrast, the voltage-
dependent Ca2+ channels are opened by the membrane depolarization induced by high K+. The 
opening of either these two channels leads to a continuous Ca2+ influx that induces contraction 
(Karaki et al., 1997). 
The results obtained in the contractility experiments demonstrate that TBT relaxes the 
aorta rings, however with a very low percentage of the effect. In fact, there are no significant 
differences between the tested TBT concentrations and their respective solvent controls which 
seem to suggest that TBT does not have a significant effect on rat aorta without endothelium.  
Nevertheless, and despite the low levels of effects observed it was possible to conclude that when 
contracted with KCl the TBT effect was more pronounced (Figure 19). The fact that TBT had more 
relaxing effects after KCl induced contraction  may suggest that TBT possible interference with the  
vascular tone is not mediated by receptor-linked Ca2+ channels as the effect after NA contraction 
was lower. NA is a neurotransmitter involved in the control of smooth muscle contraction by the 
sympathetic nervous system (Zang et al., 2006).  The sympathetic nervous system is very 
 52 
 
important for the vascular function, and the NA released from adrenergic nerves binds to α-
adrenoceptors on the plasma membrane of the vascular smooth muscle cells. This initiates 
contraction by increasing the cytoplasmic concentration of calcium, which activates the 
contractile proteins (Vanhoutte and Rimele, 1982). On the other hand, high extracellular KCl 
concentrations induce membrane depolarization which activate voltage-dependent channels such 
as L-type calcium channels that increases intracellular calcium levels leading to muscle contraction 
(Alvarez et al., 2010). It is also well known that the opening of K+ channels causes a membrane 
hyperpolarization and as a consequence closure of the voltage-gated Ca2+ channels, which 
decreases the levels of intracellular calcium and leads to the vasodilatation (relaxation) (Jackson, 
2000). Nevertheless, more studies with not only Ca+2 but also K+ channels are necessary. 
 The obtained results are somehow in accordance with the results available in the 
literature.  In fact, published works suggest that TBT effects are mostly mediated by the 
endothelium (Mizuhashi et al., 2000; Rodrigues et al., 2014), and since our artery rings didn’t have 
any endothelium this is probably the reason why in the present study we couldn’t observe a 
higher degree of relaxation upon TBT exposure. Furthermore TBT effects are suggested to be 
bidirectional causing both, the contraction and relaxation of rat aortas (Mizuhashi et al. 2000).    
Considering that calcium is the main responsible of the smooth muscle 
contraction/relaxation (Hofmann and Klugbauer, 1996)  and in order to further elucidate the 
effects of TBT on calcium currents in the L-type calcium channels of A7r5 cells, the patch clamp 
technique was used. These cells were used in the contractile phenotype because is at this stage 
they express contractile proteins that are implicated in the regulation of the vascular contractility 
(Owens, 1995). It was previously demonstrated that the calcium current measured in these cells 
was only due the LTCC (Cairrão et al., 2012). The results obtained in the electrophysiological 
experiments demonstrate that TBT inhibited the basal ICa however, at a very low level and these 
results were not significantly different between TBT concentrations and their respective controls. 
Moreover, the effects obtained were not concentration-dependent with the maximal percentage 
of relaxant effects being observed at an intermediate TBT concentration (1nM). This can be easily 
understood because TBT is an endocrine disruptor and chemicals like this do not generate the 
standard monotonic dose-response curves. In the monotonic curves the dose and response 
increases together while in non-monotonic curves the higher or lowest effects can occur at the 
intermediate doses or the higher effect can also occur at the lowest dose (Fagin, 2012).  
In conclusion, the obtained results demonstrate that TBT has no significant relaxant effect 
in rat aortas without endothelium contracted either with NA or by KCl, although KCl induced 
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higher relaxation rates. TBT seems to inhibit the L-type calcium channels although this effect was 
again not significant. Such results suggest that probably the mechanism by which TBT interferes 
with the vascular system is more complex not involving only calcium channels. 
Further studies are necessary to unveil the possible mechanism of TBT in vascular cells 
and in the arteries. Those studies include the confirmation of the obtained results with a higher 
number of artery rings and cells and also the use of specific agonists and antagonists. 
Dihydropyridines can operate as agonistics or antagonists for the LTCC thus Bay K can be used to 
stimulate the calcium channel and nifedipine to block the calcium channel (Tikhonov and Zhorov, 
2009). If the Bay K application stimulates significantly the calcium current above the basal level 
and the nifedipine significantly reduces the calcium current, this indicates that the current 
analyzed is in fact a LTCC current (Ica,L). Thus, in order to completely characterize the inhibitory 
effects of TBT on the LTCC, the effect on the Ica,L stimulated by Bay K should be performed; if TBT 
is able to inhibit the LTCC, stimulation by Bay K will confirm it.  
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4.1 Discussion and future perspectives 
 
 
The main focus of the present thesis is the study of tributyltin (TBT), a chemical included 
in the class of organotins which are considered as one of the most important organometallic 
compounds produced by humans (Fent, 2006). Historically, TBT gained notoriety due its use as a 
biocide in antifouling paints, however it usage as biocide was globally banned in 2008. During the 
decades where TBT was massively introduced in the aquatic environment the scientific 
community was engaged in the quantification of OTs environmental levels. Afterwards most of 
the publications deal with the evaluation of the efficacy of the legislation on the reduction of TBT 
environmental levels (see e.g. review by Sousa ACA et al. (2013)). Since the description of TBT 
impacts in humans, particularly in the obesogenic effects of this contaminant the number of 
publications continue to increase (Figure 21).  
 
Figure 21. Number of publications on TBT per year since 1980 until 2015. The results were obtained from a 
search performed using in Scopus data base in December of 2015 when searching for “tributyltin” in “all 
fields” between 1980 and 2015. The total number of publications retrieved was 16061. 
 
The interest in TBT has been increasing, with a minimum of 37 publications in 1980 and 
2014 being one of the years where the number of publications was highest with 834 publications 
found in this data base.  
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The introduction of TBT on the marked occurred in the late of 1950’s as an active 
ingredient in antifouling paints formulations (WHO, 1990). After several reports demonstrating 
the deleterious effects induced by this chemical, initiatives were taken by some countries and in 
1982 France was the first country to establish restrictive initiatives. In the European Union 
utilization of TBT in antifouling pains was completely ban in 2003 but only in 2008 the global ban 
entered into force. The restrictions on TBT usage in articles or part of articles, as well as in 
mixtures were regulated under European Regulations and had their effective ban in 2010 and 
2012, respectively (Sousa ACA et al., 2013).  In the Figure 21 it is possible to observe that since the 
first restrictive initiative the study of TBT has gained interest for researchers and has been 
explored in several different areas (Figure 22). The principal area where TBT is studied is 
Chemistry, followed by Environmental Science; Biochemistry, Genetics and Molecular; 
Pharmacology, Toxicology and Pharmaceutics; and Agricultural and Biological Science.  
 
Figure 22. Percentage of documents on TBT by subject area since 1980 to 2015. Data extracted 
from Scopus. 
 
Taking into account the relevance on the study of TBT, the objective of this thesis was to 
investigate the effect of this organotin compound in the regulation of blood flux in terms of 
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contractility in order to try understand the possible role of TBT at a vascular level. In this work, we 
analyzed the effects of TBT on rat aorta rings without endothelium by organ bath technique and 
on the Ica,L measured by whole cell voltage clamp in A7r5 cells. The obtained results seem to 
demonstrate that TBT induced a low percentage of relaxation on rat aortas contracted by NA and 
KCl, but this effect was not significantly different from the respective controls. TBT also seems to 
inhibit the calcium current through the L-type calcium channels but again without a significant 
difference from the ethanol control. 
The obtained results under the framework of the present thesis are preliminary ones and 
in order to understand how organotins interfere at the vascular level a more complete study will 
be necessary. To perform a more complete study other organotins should be tested, particularly 
the DBT and DOT because these are the compounds mainly used in the silicone manufacture 
included in the healthcare devices (RPA, 2005; SCHER, 2006). In the present study arteries (aorta) 
from rats and the cell line also derivated from embryonic rat aortas were used. The use of tissues 
and cells from rats, that are considered as model and are currently used in laboratory 
experiments, is essential and provides a good base of results for extrapolation to humans. 
Nevertheless, the study of organotins in human tissues and cells should be performed in order to 
better elucidate their effects in human health. To conduct this experiment it will be necessary to 
collect human umbilical cord and to isolate  human umbilical artery smooth muscle cells 
(HUASMC) (Cairrao et al., 2009). After this it will be possible to perform contractility experiments 
using a human artery and electrophysiological experiments using the HUASMC, and by this way 
study the organotins effects at a vascular level in human tissue and cells.  
Furthermore, in the present study only rapid effects, also denominated as non genomic 
effects were analyzed, but for a better understanding of TBT effects it would be important to also 
study the genomic effects. Such study is even more important because the exposure to 
environmental chemicals is prolonged and the assessment of chronic effects is necessary. Another 
important aspect to explore the effects of this compound would be to study their effect not only 
in calcium channels but also in potassium channels.  
The results obtained in this thesis suggest that   this compound does not interfere at a 
vascular level at least in the parameters studied. Nevertheless, it is well known that TBT has 
negative effects at several levels. Our results do not allow establish any relationship with 
cardiovascular diseases induced by the effects of TBT but as has often been referred throughout 
this thesis TBT is considered as an obesogen compound with capacity to increase a number of 
adiposities or increase the volume of these cells and by this way contributing to obesity (Pereira-
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Fernandes et al., 2013). Obesity is associated, among other factors, with hypertension, which is a 
prominent risk factor for the development of cardiovascular disease (Rangwala and Lazar, 2004). 
Hence, a possible relationship between the TBT effects and the development of cardiovascular 
diseases should be carefully studied considering the interplay of all these pathways.  
As long as the molecular mechanism of TBT toxicity is not fully understand a greater effort 
must be performed in order to clarify this subject.  
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